Superworth

Biotech stocks with the lowest price to sales ratio

Market value divided by revenue over the last twelve months. As of .

Ranked
62
of 146 biotech stocks we cover
Median
6.5×
Lowest
0.3×
CRIS
Range
0.3× to 52.1×
median 6.5×
0.5×51.5×
#CompanyP/SNet marginRevenue growth (TTM)Market cap
1CRISCuris0.3×n/m−62.2%$1.4M
2SCLXScilex0.5×n/m−28.5%$15.9M
3PTHSPelthos Therapeutics1.0×n/mn/m$44.1M
4CSBRChampions Oncology1.1×−1.8%+6.7%$66.9M
5TCRXTScan Therapeutics1.7×n/m+2.2%$12.1M
6AGENAgenus2.2×69.3%+30.5%$294M
7BCRXBiocryst Pharmaceuticals2.2×−40.9%+68.7%$2.1B
8MGTXMeiraGTx2.3×19.9%n/m$895.1M
9CHRSCoherus Oncology2.3×n/m+61.0%$115.8M
10PLXProtalix BioTherapeutics2.6×23.5%+30.1%$206.3M
11RGNXREGENXBIO2.7×n/m+12.0%$472.7M
12IVVDInvivyd2.9×n/m+26.3%$171.5M
13ELUTElutia3.0×n/m−18.2%$36.4M
14VYGRVoyager Therapeutics3.2×n/m−19.1%$109.7M
15AUTLAutolus Therapeutics3.2×n/m+292.2%$378M
16STROSutro Biopharma3.3×n/m−56.3%$151.1M
17IMCRImmunocore3.6×−4.2%+21.0%$1.5B
18DYAIDyadic International3.6×n/m−8.0%$13.7M
19NVAXNovavax3.8×−59.9%−61.6%$1.6B
20INCYIncyte4.2×27.7%+26.9%$24.3B
21DTILPrecision Biosciences4.3×n/mn/m$191.8M
22NBIXNeurocrine Biosciences4.4×20.9%+34.4%$14.8B
23ALNYAlnylam Pharmaceuticals4.4×16.8%+95.1%$21.2B
24LENZLENZ Therapeutics4.5×n/mn/m$95.8M
25CRBUCaribou Biosciences4.7×n/m+10.0%$47.2M
26ADMAAdma Biologics4.8×33.0%+8.0%$2.5B
27TARSTarsus Pharmaceuticals5.3×−7.7%+105.2%$3.2B
28DNAGinkgo Bioworks5.9×n/m−46.8%$663.3M
29VIRVir Biotechnology6.1×−83.0%n/m$1.9B
30FENCFennec Pharmaceuticals6.2×−5.5%+77.8%$369.6M
31REGNRegeneron Pharmaceuticals6.4×27.9%+9.3%$100B
32ONCBeOne Medicines6.6×10.7%+34.3%$40.2B
33VCELVericel6.8×7.9%+23.0%$2.1B
34FDMT4D Molecular Therapeutics6.8×n/mn/m$628.1M
35EXELExelixis7.1×35.3%+9.2%$17.4B
36UTHRUnited Therapeutics8.2×41.6%+2.5%$25.9B
37EDITEditas Medicine8.4×n/m+20.8%$394.7M
38HALOHalozyme Therapeutics8.8×24.9%+41.2%$14.6B
39TECHBIO-TECHNE9.4×15.0%−0.4%$11.4B
40VRTXVertex Pharmaceuticals10.9×35.0%+10.5%$137.1B
41IOVAIovance Biotherapeutics11.2×−89.1%+34.5%$3.6B
42CCCCC4 Therapeutics11.3×n/m+2.3%$394.9M
43ACOGAlpha Cognition11.9×n/mn/m$181.6M
44RGENRepligen12.4×5.3%+16.5%$9.8B
45ADPTAdaptive Biotechnologies13.0×−20.7%+50.1%$4B
46PLURPluri14.6×n/m−24.0%$14.8M
47BEAMBeam Therapeutics17.1×−54.7%+163.3%$2.7B
48ALECAlector17.3×n/m−82.9%$240.1M
49TWSTTwist Bioscience18.7×−31.7%+19.2%$8.1B
50LCTXLineage Cell Therapeutics19.5×n/m+19.9%$255.4M
51KRYSKrystal Biotech19.9×54.8%+22.6%$8.8B
52VIVSVivoSim Labs, INC.20.3×n/m−21.1%$2.3M
53INSMInsmed20.8×−76.9%+185.8%$23.7B
54XFORX4 Pharmaceuticals21.0×n/m−51.6%$332.1M
55SRZNSurrozen29.6×n/m−8.8%$341.1M
56GLUEMonte Rosa Therapeutics31.6×n/m−83.9%$906.9M
57FATEFate Therapeutics37.1×n/m−23.4%$240.8M
58RXRXRecursion Pharmaceuticals37.4×n/m+56.2%$2.1B
59MRNAModerna41.3×n/m−27.6%$92.1B
60IBRXImmunityBio50.8×n/m+192.9%$8.4B
61AIMAIM ImmunoTech51.5×n/m−21.5%$4.9M
62HUMAHumacyte52.1×n/m+159.3%$110.6M

Not ranked: 31 with not a meaningful number, 16 with a quarter missing, 7 with a value too high to mean anything, 4 with a value above 100× (too small a base to compare), 3 with no price to sales (not meaningful for banks and some insurers). 23 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

P/S for other groups

Other rankings of biotech stocks

The group